HPV-Associated Head and Neck Cancer: Molecular and Nano-Scale Markers for Prognosis and Therapeutic Stratification

Clicks: 253
ID: 111669
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Over the last 10 years, it has become clear that patients with head and neck cancer can be stratified into two distinct subgroups on the basis of the etiology of their disease. Patients with human papillomavirus-related cancers have significantly better survival rates and may necessitate different therapeutic approaches than those with tobacco and/or alcohol related cancers. This review discusses the various biomarkers currently in use for identification of patients with HPV-positive cancers with a focus on the advantages and limitations of molecular and nano-scale markers.
Reference Key
kimple2012sensorshpv-associated Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Adam J. Kimple;Alexandra D. Torres;Robert Z. Yang;Randall J. Kimple;Kimple, Adam J.;Torres, Alexandra D.;Yang, Robert Z.;Kimple, Randall J.;
Journal sensors
Year 2012
DOI
10.3390/s120405159
URL
https://www.mdpi.com/1424-8220/12/4/5159#citedby
Keywords
biomarkers next generation sequencing head and neck cancer human papillomavirus in situ hybridization

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.